ESR1 and triple-negative breast carcinoma: These subtypes include estrogen receptor-positive (ER+), progesterone receptor-positive (PR+), Human epidermal growth factor receptor-2-positive (HER2+), and triple-negative breast cancer (TNBC) (1).